Drug name - Skyla
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7252839 | BAYER HLTHCARE | Delivery system and a manufacturing process of a delivery system |
Nov, 2023
(1 year, 1 month from now) | |
| US9615965 | BAYER HLTHCARE | Inserter |
Sep, 2029
(6 years from now) | |
| US10561524 | BAYER HLTHCARE | Inserter |
Sep, 2029
(6 years from now) | |
| US10987244 | BAYER HLTHCARE | Inserter |
Apr, 2031
(8 years from now) | |
| US9668912 | BAYER HLTHCARE | Inserter |
Apr, 2031
(8 years from now) | |
Drugs and Companies using LEVONORGESTREL ingredient
Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system; A method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus
Dosage: INTRAUTERINE DEVICE;INTRAUTERINE
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 13.5MG | INTRAUTERINE DEVICE;INTRAUTERINE | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.